Benatar M

References (5)

Title : ALSUntangled #81: Pyridostigmine (mestinon()) - Mansoor_2025_Amyotroph.Lateral.Scler.Frontotemporal.Degener__1
Author(s) : Mansoor N , Heiman-Patterson T , Feldman EL , Wicks P , Benatar M , Vieira F , Glass J , Levine T , Bertorini T , Barkhaus P , Mascias Cadavid J , Jackson C , Jhooty S , Brown A , Pattee G , Sane H , McDermott CJ , Carter G , Beauchamp M , Wang O , Ratner D , Bedlack R , Li X
Ref : Amyotroph Lateral Scler Frontotemporal Degener , :1 , 2025
Abstract :
PubMedSearch : Mansoor_2025_Amyotroph.Lateral.Scler.Frontotemporal.Degener__1
PubMedID: 41196032

Title : Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barre Syndrome - Lizarraga_2016_Semin.Neurol_36_615
Author(s) : Lizarraga AA , Lizarraga KJ , Benatar M
Ref : Semin Neurol , 36 :615 , 2016
Abstract :
PubMedSearch : Lizarraga_2016_Semin.Neurol_36_615
PubMedID: 27907966

Title : Design of the Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) trial - Benatar_2012_Ann.N.Y.Acad.Sci_1275_17
Author(s) : Benatar M , Sanders DB , Wolfe GI , McDermott MP , Tawil R
Ref : Annals of the New York Academy of Sciences , 1275 :17 , 2012
Abstract :
PubMedSearch : Benatar_2012_Ann.N.Y.Acad.Sci_1275_17
PubMedID: 23278573

Title : Treatment of ocular symptoms in myasthenia gravis - Bhanushali_2008_Neurology_71_1335
Author(s) : Bhanushali MJ , Wuu J , Benatar M
Ref : Neurology , 71 :1335 , 2008
Abstract :
PubMedSearch : Bhanushali_2008_Neurology_71_1335
PubMedID: 18936425

Title : Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology - Benatar_2007_Neurology_68_2144
Author(s) : Benatar M , Kaminski HJ
Ref : Neurology , 68 :2144 , 2007
Abstract :
PubMedSearch : Benatar_2007_Neurology_68_2144
PubMedID: 17460154